Expanded OEM portfolio, modernization initiatives, and collaborative innovation experiences position Catalyst MedTech as a leading partner for nuclear medicine and molecular imaging providers nationwi ...
“Our record 2024 performance is a reflection of Catalyst’s successful launch of AGAMREE and our continued outstanding commercial capabilities that fuel the momentum of our existing products,” said ...
A visualization of the exterior of the Catalyst building when completed from a bird’s-eye view. Renderings courtesy of Koelbel and Company. A new healthcare innovation hub opening in Omaha in early ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Catalyst continues to actively enroll patients in the SUMMIT study, an open-label five-year follow-up study designed to evaluate the long-term clinical safety profile of AGAMREE, including potential ...
CVE-2026-20182 bypasses Cisco SD-WAN auth via DTLS port 12346, enabling admin access after May 2026 exploitation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results